Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Lucia Caiano, Rhys Sharkey, Marc A. Rodger, Michael J. Kovacs, Grégoire Le Gal, Aurélien Delluc. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study. Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017 Year: 2018 Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case?control study from Sweden Source: Eur Respir J , 49 (2) 1601014; DOI: 10.1183/13993003.01014-2016 Year: 2017 The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Influence of the initial venous thrombo-embolism event on outcome in patients with COPD: Findings from the RIETE registry Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017 Year: 2017 Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016 Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012 Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002 Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018 Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015 Can syncope be used for the risk assessment of pulmonary embolism? Source: International Congress 2017 – Pulmonary embolism Year: 2017 Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Asthma and risk of pulmonary thromboembolism Source: Eur Respir J 2014; 43: 1534-1535 Year: 2014 Clinical profile and mortality of patients with pulmonary embolism and cancer Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009